Publications
368
Citations
20,890
Est. group size
~9
Recurring co-author estimate
Active years
39
Publishing since 1987
Typically publishes in teams of ~7 · 9% small-team papers (≤3 authors) · across 46 venues
- Evaluation of antimicrobial susceptibility testing methods for <i>Burkholderia cepacia</i> complex isolates from people with and without cystic fibrosis
Journal of Clinical Microbiology · 2025
- Impact of the SARS-CoV-2 pandemic on cystic fibrosis centres and care: survey results from US centres
UNC Libraries · 2025
- Practical Guidance for Clinical Microbiology Laboratories: Updated guidance for processing respiratory tract samples from people with cystic fibrosis
Clinical Microbiology Reviews · 2024
- Assessing effectiveness of cleaning and disinfection of equipment and environmental surfaces in cystic fibrosis clinics using an ATP assay
Infection Control and Hospital Epidemiology · 2024
- Frameshift Mutations in Genes Encoding PBP3 and PBP4 Trigger an Unusual, Extreme β-Lactam Resistance Phenotype in <i>Burkholderia multivorans</i>
ACS Infectious Diseases · 2024
- A Comparative Metagenomic Analysis of Specified Microorganisms in Groundwater for Non-Sterilized Pharmaceutical Products
Current Microbiology · 2024
- WS09.03 Exploring the constitution and dynamics of the cystic fibrosis sputum phageome
Journal of Cystic Fibrosis · 2024
- 70 Evaluation of the ETEST gradient diffusion method for antimicrobial susceptibility testing of the Burkholderia cepacia complex
Journal of Cystic Fibrosis · 2024
- A Metagenomic Analysis with Oligotrophic Enrichment Approach for Detecting Specified Microorganisms
PDA Journal of Pharmaceutical Science and Technology · 2024
- Phage therapy in a lung transplant recipient with cystic fibrosis infected with multidrug‐resistant <i>Burkholderia multivorans</i>
Transplant Infectious Disease · 2023
- Longitudinal bacterial prevalence in cystic fibrosis airways: Fact and artifact
Journal of Cystic Fibrosis · 2023
- Characterizing Biofilm Interactions between <i>Ralstonia insidiosa</i> and <i>Chryseobacterium gleum</i>
Microbiology Spectrum · 2023
- Examining the activity of cefepime-taniborbactam against <i>Burkholderia cepacia</i> complex and <i>Burkholderia gladioli</i> isolated from cystic fibrosis patients in the United States
Antimicrobial Agents and Chemotherapy · 2023
- Association of Pseudomonas aeruginosa incident infections with adherence to cystic fibrosis foundation care guidelines
Journal of Cystic Fibrosis · 2023
- Outbreak of <i>Burkholderia multivorans</i> among patients at two acute-care hospitals in California, August 2021–July 2022
Antimicrobial Stewardship & Healthcare Epidemiology · 2023
- Journal of Cystic Fibrosis×28
- Antimicrobial Agents and Chemotherapy×12
- Genome Announcements×8
- Annals of the American Thoracic Society×6
- PLoS ONE×5
- Theodore Spilker
Medicine · University of Michigan
- Sankalp Malhotra
Medicine · The Ohio State University
- Annie Lu
Medicine · University of Michigan
- Lisa A. Carmody
Medicine · University of Michigan
- Christina S. Thornton
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile